Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD) Company Bio
Gilead Sciences is a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
GILD Stock Chart More Charts
GILD Price/Volume Stats
| Current price | $67.59 |
| Prev. close | $66.37 |
| Day low | $66.50 |
| Day high | $67.69 |
| 50-day MA | $67.01 |
| 200-day MA | $71.12 |
| 52-week high | $82.71 |
| 52-week low | $60.32 |
| Volume | 6,214,200 |
| Avg. volume | 7,949,650 |
| Dividend yield | 3.44% |
| Market Cap | 87.44B |
GILD Returns
| 1-mo | -1.54% |
| 3-mo | -1.50% |
| 6-mo | -5.07% |
| 1-year | -13.59% |
| 3-year | -17.83% |
| 5-year | -8.51% |
| YTD | 8.06% |
| 2018 | -9.92% |
| 2017 | 2.96% |
| 2016 | -27.59% |
| 2015 | 8.63% |
| 2014 | 25.51% |
GILD Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...